Wockhardt likely to sell India business to cut debt, focus on UK: Analysts

Company left with low-margin brands in India after selling profitable ones

Wockhardt, the international pharmaceuticals company, is likely to focus on its UK operations and sell the low-margin India business to pare debt, analysts have said.

Two Mumbai-based analysts told 'Business Standard' that Wockhardt had few options besides selling its Rs 670-crore domestic business. “This is the only business vertical that it can sell, and can fetch about 3-4 times the revenue multiple easily. Many players are looking for brand acquisitions if they come at a reasonable price,” said one analyst, adding that Wockhardt’s next step would be to focus on its UK and EU businesses.

Another analyst said the company